Ono Pharmaceutical announced that consolidated operating profit is expected to be ¥94 billion for the fiscal year ending March 2027. It is reported that the IFRS-based forecast will remain unchanged.
Ono Pharmaceutical announced that consolidated operating profit is expected to be ¥94 billion for the fiscal year ending March 2027. The specific figure is presented as an expected profit.
Information announced the same day reportedly includes a policy of keeping the earnings forecast based on IFRS unchanged.